Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Health News Biogen To Pay Forward Pharma 1 25 Billion To Protect Ms Drug is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Biogen stock rises on sales of groundbreaking Alzheimer's drug
Biogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge, Massachusetts-based pharmaceutical company reported higher than expected sales of its groundbreaking ... Read More
Biogen 'turning the corner' as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO
While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks—thanks in large part to accelerating launches of new drugs like Leqembi and Skyclarys—the CEO ... Read More
Biogen CEO Chris Viehbacher sees 2023 pay fall to $4M after massive welcome package
After getting a fat check worth $30.5 million for joining Biogen as the CEO in late 2022, Chris Viehbacher saw his 2023 pay drop to $4.1 million as the Big Biotech continues to struggle. | After ... Read More
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
Biogen reports Q1 results: adjusted EPS $3.67 (beat consensus), sales $2.29 billion (missed consensus). Leqembi launch uptake triples, Zurzuvae's early trends encouraging. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus